Health

If needed, with the Moderna or Pfizer vaccine, a second dose is required by Nov. 15.

In a 19-0 vote, the panel recommended that the booster dose come at least two months after initial immunization with one shot of the J&J vaccine.

The Department of Health and Human Services (HHS) is now committing $100 million through the American Rescue Plan to help solve the problem.

In two weeks, about 400 Hospital of the University of Pennsylvania patients will be wheeled out of their units. Thursday was the final dress rehearsal.

The U.S. donation from its domestic supplies comes on top of the 50 million doses previously donated to Africa, which world health officials say is 500 million doses short of

The advisers to the Food and Drug Administration voted Thursday to recommend a lower-dose booster shot for seniors and other high-risk groups.

We're joined by Daniel Lieberman, author of Exercised: Why Something We Never Evolved to Do Is Healthy and Rewarding

Putting off surgeries or routine treatments for serious illnesses has become common during the pandemic, a new NPR/Harvard poll finds.

New Jersey will use federal stimulus dollars to offer $1,000 bonuses to help child care providers recruit new workers and retain existing staff.

Even amid the coronavirus pandemic, heart disease continues to be the nation's leading cause of death. And much of it is preventable through a healthier diet.

Philadelphia’s health commissioner said the city risks another epidemic of preventable deaths if health care workers don’t get inoculated against the coronavirus.

Delco’s health department could be created this month, but it won’t have any power until the Pennsylvania Department of Health gives the final stamp of approval.

After the FDA advisers give their recommendation, the agency itself will make an official decision on whether to authorize boosters.

The NJ gubernatorial race, nursing shortages and Sonia Manzano, who played the role of Maria on Sesame Street, on the new PBS show "Alma's Way, inspired by her life.

The FDA will scrutinize company data on the safety and effectiveness of the drug, molnupiravir, before rendering a decision.